Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP317288.RACFSoUzOr-spv9UculvR6TNxPsCIv84UmXySA04b_ZOc130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317288.RACFSoUzOr-spv9UculvR6TNxPsCIv84UmXySA04b_ZOc130_provenance.
• NP387416.RAAYt3n_yKL4w_NywNNSDcxokXWgs2MYD41w9s_zKN5io130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387416.RAAYt3n_yKL4w_NywNNSDcxokXWgs2MYD41w9s_zKN5io130_provenance.
• NP150912.RA1bSUjywFnf8xvdmdo9BW9StOeGBX4NOed9wunzG5i4w130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150912.RA1bSUjywFnf8xvdmdo9BW9StOeGBX4NOed9wunzG5i4w130_provenance.
• NP387250.RAcm9MSgtRJtLGF4ulkjZhf0XeSYmNHOIhlfUmZ3pPBmg130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387250.RAcm9MSgtRJtLGF4ulkjZhf0XeSYmNHOIhlfUmZ3pPBmg130_provenance.
• assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP285414.RAKp3R1v2pc7dhfqa06gB5Kg6G9b5u30w-Qxxh8QMnNVQ130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285414.RAKp3R1v2pc7dhfqa06gB5Kg6G9b5u30w-Qxxh8QMnNVQ130_provenance.
• assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP317141.RAl2aJFnqIkOG-wgXzytL4JCP9oRgQuzH1s2gpdjSQ4-g130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing 'best' and 'worst' risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317141.RAl2aJFnqIkOG-wgXzytL4JCP9oRgQuzH1s2gpdjSQ4-g130_provenance.